Myasthenia Severe Pseudoparalytic (Myasthenia Gravis): causes, symptoms and treatment
Myasthenia Severe Pseudoparalytic (Myasthenia Gravis) is a chronic disease characterized by increased human fatigue and weakness of individual muscle groups. However, it is important to note that this weakness improves with rest or with medications containing anticholinesterase. The fatigue associated with Myasthenia Gravis can be so severe that temporary paralysis of individual muscles can occur as a result of significant overexertion.
Symptoms of Myasthenia Gravis can vary but often include drooping of the upper eyelid (ptosis), double vision and dysarthria. Ptosis occurs as a drooping upper eyelid, which can cause a feeling of heaviness and fatigue around the eyes. Double vision occurs due to poor eye muscle coordination and can severely limit a person's ability to read, drive, or perform other daily tasks. Dysarthria, or impaired articulation, can manifest itself as weakness of the speech muscles, which affects the clarity and understanding of words.
The causes of Myasthenia Gravis are still not fully understood, but it is known that the disease is associated with an impairment of the ability of the neurotransmitter acetylcholine to cause muscle contractions. This may be due to the presence of autoimmune antibodies that attack acetylcholine receptors on the surface of the muscles. As a result, muscle contraction becomes difficult and leads to weakness.
Myasthenia Gravis mainly occurs in adolescents, young adults (usually women) and adults over 40 years of age. The severity of the disease can range from mild to severe cases that can lead to significant limitations in daily life.
Treatment for Myasthenia Gravis may include drug therapy and surgical removal of the thymus, which is an immunological gland associated with the development of the disease. The goal of drug therapy is to increase acetylcholine levels in the synaptic cleft, which helps improve muscle strength and function. In some cases, severely ill people may be given steroids or blood plasma transfusions to reduce symptoms.
Surgical removal of the thymus may be recommended in cases where the gland becomes overactive or tumors are found. Removing the thymus gland may help reduce the symptoms of Myasthenia Gravis and improve the patient's overall condition.
It is important to note that Myasthenia Gravis is a chronic disease and its treatment must be ongoing and individualized for each patient. Regular follow-up with a doctor and adherence to treatment and rehabilitation recommendations play an important role in managing this condition.
Research into Myasthenia Gravis continues, and new treatments and approaches to managing the disease are constantly being developed. It is important to stay informed about the latest advances in medicine and consult with qualified professionals to receive the best care and treatment possible.
Overall, Myasthenia Gravis is a serious condition that can significantly impact patients' quality of life. However, modern treatment and management methods can significantly reduce symptoms and improve life prospects for people suffering from this condition.
Myasthenia gravis pseudoparalytic The author of the article is a professional physician specializing in the treatment of mental disorders, depression and anxiety.
In modern conditions of the development of science and medicine, the study of new syndromes and diseases associated with dysfunction of the nervous system is becoming an urgent task. One such problem is pseudoparalysis.
Pseudoparalysis is a complex of symptoms expressed in the weakness of skeletal muscles, resulting from a decrease in muscle tone or a decrease in muscle strength to its absence.
Myasthenia gravis (also known as myasthenic gravis syndrome) is also known as "Gravis syndrome". The term was coined in the early 20th century to describe a severe disease that affects not only the nerves but also the muscles. This condition greatly affects the lives of patients and requires special attention from doctors.